Precision cancer medicine requires effective genotyping of every patient's tumor to optimally design treatment plans. Despite its imperfect sensitivity, the rapidity and convenience of cell-free DNA (cfDNA) sequencing makes it an essential complement to tumor genotyping which, when used appropriately, can aide the pursuit of effective genotyping for all patients.
Read Full Article
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου